Inhibrx Biosciences, Inc. INBX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares)?
- Inhibrx Biosciences, Inc. (INBX) reported common stock, shares authorized (in shares) of $120M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $120M to $120M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $120M to $120M.